The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation
Open accessAbstract
Ischemia followed by reperfusion leads to severe organ injury and dysfunction. Inflammation is considered to be the most important cause of tissue injury in organs subjected to ischemia. The mechanism that triggers inflammation and organ injury after ischemia remains to be elucidated, although different causes have been postulated. We investigated the role of apoptosis in the induction of inflammation and organ damage after renal ischemia. Using a murine model, we demonstrate a relationship between apoptosis and subsequent inflammation. At the time of reperfusion, administration of the antiapoptotic agents IGF-1 and ZVAD-fmk (a caspase inactivator) prevented the early onset of not only renal apoptosis, but also inflammation and tissue injury. Conversely, when the antiapoptotic agents were administered after onset of apoptosis, these protective effects were completely abrogated. The presence of apoptosis was directly correlated with posttranslational processing of the endothelial monocyte-activating polypeptide II (EMAP-II), which may explain apoptosis-induced influx and sequestration of leukocytes in the reperfused kidney. These results strongly suggest that apoptosis is a crucial event that can initiate reperfusion-induced inflammation and subsequent tissue injury. The newly described pathophysiological insights provide important opportunities to effectively prevent clinical manifestations of reperfusion injury in the kidney, and potentially in other organs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vlahos, C. J., Matter, W. F., Hui, K. Y., & Brown, R. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37680-9 · Cited by 3,240
Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., & Henson, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1112 · Cited by 3,166 · cited 1×
“which states that apoptosis represents a physiological mode of cell deletion allowing disposal of superfluous cells with minimal tissue reaction, or even with active restraining of inflammation (5).”
BackgroundCleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE
Lazebnik, Y. A., Kaufmann, S. H., Desnoyers, S., Poirier, G. G., & Earnshaw, W. C. (1994) · Nature · doi:10.1038/371346a0 · Cited by 2,562
Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN- γ production
Ghayur, T., Banerjee, S., Hugunin, M., Butler, D., Herzog, L., Carter, A., Quintal, L., Sekut, L., Talanian, R., Paskind, M., et al. (1997) · Nature · doi:10.1038/386619a0 · Cited by 1,203
Kulik, G., Klippel, A., & Weber, M. J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1595 · Cited by 1,040
Apoptosis: The Biochemistry and Molecular Biology of Programmed Cell Death*
SCHWARTZMAN, R. A., & CIDLOWSKI, J. A. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-2-133 · Cited by 1,040
Párrizas, M., Saltiel, A. R., & LeRoith, D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.1.154 · Cited by 653
Attenuation of Ischemia/Reperfusion Injury in Rats by a Caspase Inhibitor
Yaoita, H., Ogawa, K., Maehara, K., & Maruyama, Y. (1998) · Circulation · doi:10.1161/01.cir.97.3.276 · Cited by 626
Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis
Los, M., Craen, M. V. D., Penning, L. C., Schenk, H., Westendorp, M., Baeuerle, P. A., Dröge, W., Krammer, P. H., Fiers, W., & Schulze-Osthoff, K. (1995) · Nature · doi:10.1038/375081a0 · Cited by 607
Nitric Oxide Reversibly Inhibits Seven Members of the Caspase Family via S-Nitrosylation
Li, J., Billiar, T. R., Talanian, R. V., & Kim, Y. M. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7672 · Cited by 529
Cited by
Cell Biology of Ischemia/Reperfusion Injury
(2012) · International Review of Cell and Molecular Biology · doi:10.1016/b978-0-12-394309-5.00006-7 · Cited by 2,178
Caspase structure, proteolytic substrates, and function during apoptotic cell death
Nicholson, D. (1999) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400598 · Cited by 1,543
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
Sirén, A.-L., Fratelli, M., Brines, M., Goemans, C., Casagrande, S., Lewczuk, P., Keenan, S., Gleiter, C., Pasquali, C., Capobianco, A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051606598 · Cited by 1,019
Ischemia–Reperfusion–induced Lung Injury
de Perrot, M., Liu, M., Waddell, T. K., & Keshavjee, S. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200207-670so · Cited by 962
More than one way to die: apoptosis, necrosis and reactive oxygen damage
Fiers, W., Beyaert, R., Declercq, W., & Vandenabeele, P. (1999) · Oncogene · doi:10.1038/sj.onc.1203249 · Cited by 864
Self-citationTARASEVICIENE‐STEWART, L., KASAHARA, Y., ALGER, L., HIRTH, P., MAHON, G. M., WALTENBERGER, J., VOELKEL, N. F., & TUDER, R. M. (2001) · The FASEB Journal · doi:10.1096/fj.00-0343com · Cited by 817
Recent Advances in the Pathophysiology of Ischemic Acute Renal Failure
Bonventre, J. V., & Weinberg, J. M. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000079785.13922.f6 · Cited by 767
Kalogeris, T., Baines, C. P., Krenz, M., & Korthuis, R. J. (2016) · Comprehensive Physiology · doi:10.1002/cphy.c160006 · Cited by 718
From bench to clinic with apoptosis-based therapeutic agents
Nicholson, D. W. (2000) · Nature · doi:10.1038/35037747 · Cited by 687
Apoptosis and acute kidney injury
Havasi, A., & Borkan, S. C. (2011) · Kidney International · doi:10.1038/ki.2011.120 · Cited by 653
Erber, R., Thurnher, A., D. Katsen, A., Groth, G., Kerger, H., Hammes, H., D. Menger, M., Ullrich, A., & Vajkoczy, P. (2004) · The FASEB Journal · doi:10.1096/fj.03-0271fje · Cited by 610
Linkermann, A., Chen, G., Dong, G., Kunzendorf, U., Krautwald, S., & Dong, Z. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014030262 · Cited by 563
Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney
Leemans, J. C., Stokman, G., Claessen, N., Rouschop, K. M., Teske, G. J. D., Kirschning, C. J., Akira, S., van der Poll, T., Weening, J. J., & Florquin, S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci22832 · Cited by 563
Impaired IL-18 processing protects caspase-1–deficient mice from ischemic acute renal failure
Melnikov, V. Y., Ecder, T., Fantuzzi, G., Siegmund, B., Lucia, M. S., Dinarello, C. A., Schrier, R. W., & Edelstein, C. L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12089 · Cited by 476
Differential gene expression following early renal ischemia/reperfusion
Supavekin, S., Zhang, W., Kucherlapati, R., Kaskel, F. J., Moore, L. C., & Devarajan, P. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00928.x · Cited by 465
Linkermann, A., Bräsen, J. H., Himmerkus, N., Liu, S., Huber, T. B., Kunzendorf, U., & Krautwald, S. (2012) · Kidney International · doi:10.1038/ki.2011.450 · Cited by 461
Wolfs, T. G. A. M., Buurman, W. A., van Schadewijk, A., de Vries, B., Daemen, M. A. R. C., Hiemstra, P. S., & van ’t Veer, C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1286 · Cited by 442
Self-citationErythropoietin Protects the Kidney against the Injury and Dysfunction Caused by Ischemia-Reperfusion
Sharples, E. J., Patel, N., Brown, P., Stewart, K., Mota-Philipe, H., Sheaff, M., Kieswich, J., Allen, D., Harwood, S., Raftery, M., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000135059.67385.5d · Cited by 402
Regulated cell death pathways in kidney disease
Sanz, A. B., Sanchez-Niño, M. D., Ramos, A. M., & Ortiz, A. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00694-0 · Cited by 393
Padanilam, B. J. (2003) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00284.2002 · Cited by 372
Apoptotic cell death in disease—Current understanding of the NCCD 2023
Vitale, I., Pietrocola, F., Guilbaud, E., Aaronson, S. A., Abrams, J. M., Adam, D., Agostini, M., Agostinis, P., Alnemri, E. S., Altucci, L., et al. (2023) · Cell Death & Differentiation · doi:10.1038/s41418-023-01153-w · Cited by 361
Self-citationAcute Renal Failure in Endotoxemia Is Caused by TNF Acting Directly on TNF Receptor-1 in Kidney
Cunningham, P. N., Dyanov, H. M., Park, P., Wang, J., Newell, K. A., & Quigg, R. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5817 · Cited by 359
Melnikov, V. Y., Faubel, S. G., Siegmund, B., Lucia, M. S., Ljubanović, D. G., & Edelstein, C. L. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15623 · Cited by 341
siRNA Targeted to p53 Attenuates Ischemic and Cisplatin-Induced Acute Kidney Injury
Molitoris, B. A., Dagher, P. C., Sandoval, R. M., Campos, S. B., Ashush, H., Fridman, E., Brafman, A., Faerman, A., Atkinson, S. J., Thompson, J. D., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008111204 · Cited by 337
Kühn, K., D’Lima, D. D., Hashimoto, S., & Lotz, M. (2004) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2003.09.015 · Cited by 317
Melnikov, V. Y., Faubel, S., Siegmund, B., Lucia, M. S., Ljubanovic, D., & Edelstein, C. L. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215623 · Cited by 316
Oxidized LDL, LOX-1 and Atherosclerosis
Mitra, S., Goyal, T., & Mehta, J. L. (2011) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-011-6341-5 · Cited by 300
Lotz, M. K. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3046 · Cited by 294
Apoptotic and necrotic cell death induced by death domain receptors
Denecker, G., Vercammen, D., Declercq, W., & Vandenabeele, P. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000863 · Cited by 279
Self-citationHepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis
Natori, S., Rust, C., Stadheim, L. M., Srinivasan, A., Burgart, L. J., & Gores, G. J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00089-1 · Cited by 273
New Approaches and Therapeutics Targeting Apoptosis in Disease
Fischer, U., & Schulze-Osthoff, K. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.6 · Cited by 257
Pharmacologic Treatment of Acute Kidney Injury: Why Drugs Haven’t Worked and What Is on the Horizon
Jo, S. K., Rosner, M. H., & Okusa, M. D. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03280906 · Cited by 252
Devarajan, P., Mishra, J., Supavekin, S., Patterson, L. T., & Steven Potter, S. (2003) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2003.09.012 · Cited by 229
Herzog, C., Yang, C., Holmes, A., & Kaushal, G. P. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00659.2011 · Cited by 82
Nitro-oleic acid protects the mouse kidney from ischemia and reperfusion injury
Liu, H., Jia, Z., Soodvilai, S., Guan, G., Wang, M.-H., Dong, Z., Symons, J. D., & Yang, T. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90236.2008 · Cited by 66
Early peri-operative hyperglycaemia and renal allograft rejection in patients withoutdiabetes
Thomas, M. C., Moran, J., Mathew, T. H., Russ, G. R., & Mohan Rao, M. (2000) · BMC Nephrology · doi:10.1186/1471-2369-1-1 · Cited by 60
Bao, L., Wang, Y., Chang, A., Minto, A. W., Zhou, J., Kang, H., Haas, M., & Quigg, R. J. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006101176 · Cited by 51
Metadata
- Authors
- Daemen, M. A. R. C., van ‘t Veer, C., Denecker, G., Heemskerk, V. H., Wolfs, T. G. A. M., Clauss, M., Vandenabeele, P., & Buurman, W. A.
- Venue
- Journal of Clinical Investigation
- Published
- 1999-09-01
- Volume
- 104
- Issue
- 5
- Pages
- 541-549
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2089031022
- Cited by
- 566
- References
- 35
- FWCI
- 22.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.